Bengaluru
Vizzhy Inc, a leading Indian company, is propelling a healthcare revolution by channeling the potent combination of Multi-omics and Generative AI to tackle the root causes of metabolic diseases. With a commitment to invest $12.5 million in an American university, the company is set to explore novel avenues in the management of metabolic diseases.
A Memorandum of Understanding (MoU) between the University of Illinois Urbana-Champaign, a prestigious institution known for its Grainger Engineering School, and Vizzhy Inc, was formally signed at an event held in the city.
Speaking at the occasion, the Minister for Youth Empowerment, Sports, and Tribal Welfare B Nagendra emphasised the importance of research as the cornerstone of addressing various societal challenges. The government of Karnataka is placing significant emphasis on research and development with the establishment of the Karnataka Research Foundation, and it welcomes investments from companies like Vizzhy Inc in the R&D sector with full government support.
The Founder and CEO of Vizzhy Inc Dr. Vishnuvardhan noted that startling findings from the 2019 NHANES survey, which revealed that 88 percent of adults are metabolically unfit and that the average adult has gained 15kg since the 1970s, have prompted the company to redefine the healthcare landscape. This surge in metabolic diseases has propelled annual healthcare spending in the US to over $4 trillion, surpassing India’s GDP.
